Literature DB >> 857617

Purine and pyrimidine nucleotide concentrations in cells with decreased hypoxanthine-guanine-phosphoribosyltransferase (HGPRT) activity.

G Nuki, K Astrin, D Brenton, M Cruikshank, J Lever, J E Seegmiller.   

Abstract

1. In order to investigate the role of purine ribonucleotides in the regulation of de novo purine synthesis in living human cells deficient in HGPRT, intracellular ribonucleotide concentrations have been measured in HGPRT lymphoblasts, fibroblasts and erythrocytes and in appropriate HGPRT controls by high pressure liquid chromatography. 2. Purine Purine ribonucleotide concentrations were not reduced in HGPRT cells, supporting the hypothesis that accelerated purine biosynthesis de novo results from increased availability of PP-ribose-P and not from altered feedback regulation by purine ribonucleotides in HGPRT deficient cells. 3. Striking increases in intracellular concentrations of some pyrimidine nucleotides and nucleotide sugars were detected in HGPRT lymphoblasts and erythrocytes, but not in fibroblasts. 4. The possibiiity that this abnormality of pyrimidine metabolism might result from coordinate regulation of purine and pyrimidine synthesis de novo by PP-ribose-P was not substantiated by measurements of rates of pyrimidine synthesis and experimental elevation of intracellular concentrations of PP-ribose-P following incubation of cells with inorganic phosphate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 857617     DOI: 10.1007/978-1-4613-4223-6_41

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

Authors: 
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 2.  Human purine metabolism: some recent advances and relationships with immunodeficiency.

Authors:  G Nuki
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

3.  Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients.

Authors:  Lynette D Fairbanks; Gabriella Jacomelli; Vanna Micheli; Tina Slade; H Anne Simmonds
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

4.  Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways.

Authors:  Rong Fu; Diane Sutcliffe; Hong Zhao; Xinyi Huang; David J Schretlen; Steve Benkovic; H A Jinnah
Journal:  Mol Genet Metab       Date:  2014-11-08       Impact factor: 4.797

5.  Altered purine and pyrimidine metabolism in erythrocytes with purine nucleoside phosphorylase deficiency.

Authors:  I H Fox; J Kaminska; N L Edwards; E Gelfand; K C Rich; W N Arnold
Journal:  Biochem Genet       Date:  1980-04       Impact factor: 1.890

6.  Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage.

Authors:  N L Edwards; D Recker; I H Fox
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.

Authors:  A Cohen; R Hirschhorn; S D Horowitz; A Rubinstein; S H Polmar; R Hong; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.